Julien Sebag

Julien Sebag
Associate Professor of Pharmacology
Medical School
[email protected]
Available to mentor
Julien Sebag
Julien Sebag
Associate Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Recent Publications
  • Manage Your Profile

  • About

    Our laboratory focuses on identifying new pathways involved in the control of energy and glucose homeostasis and discovering novel targets for the treatment of obesity and diabetes. Our main focus is understanding the role and mechanism of GPCR regulation by the Melanocortin Receptor Accessory Protein 2 (MRAP2). MRAP2 is a critical protein for the maintenance of proper energy and glucose balance. Deletion of MRAP2 causes obesity and insulin resistance, however, the mechanisms involved are poorly understood. We are also studying new regulators of insulin-stimulated GLUT4 translocation using high throughput screening and structural biology.

    Links

    • Lab Website

    Qualifications

    • PhD
      University of Rochester Medical Center, Rochester, United States

    Center Memberships

    • Center Member
      Caswell Diabetes Institute

    Recent Publications

    See All Publications
    • Preprint
      Attractin-Like Protein 1 (ATRNL1): An Essential Partner of MC4R to Regulate Body Weight
      Buscaglia P, Bowman KR, Lawler K, Hernandez CC, Scotucci J, Bounds R, Keogh JM, Henning E, Cone RD, Farooqi IS, Sebag JA. 2026 Jan 19; medRxiv, DOI:10.64898/2026.01.12.26343722
    • Journal Article
      Inhibition of Unc119b improves insulin sensitivity through potentiation of Rac1 activation in skeletal muscle and brown adipose tissue
      Mittal A, Buscaglia P, Srivastava D, Artemyev NO, Sebag JA. Molecular Metabolism, 2025 Oct 1; 100: DOI:10.1016/j.molmet.2025.102230
      PMID: 40754229
    • Journal Article
      Insulin sensitization by small molecules enhancing GLUT4 translocation
      Yin TC, Van Vranken JG, Srivastava D, Mittal A, Buscaglia P, Moore AE, Verdinez JA, Graham AE, Walsh SA, Acevedo MA, Kerns RJ, Artemyev NO, Gygi SP, Sebag JA. Cell Chemical Biology, 2023 Aug 17; 30 (8): 933 - 942.e6. DOI:10.1016/j.chembiol.2023.06.012
      PMID: 37453421
    • Journal Article
      Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2
      Yin TC, Mittal A, Buscaglia P, Li W, Sebag JA. Journal of Biological Chemistry, 2023 Jan 1; 299 (1): DOI:10.1016/j.jbc.2022.102814
      PMID: 36539034
    • Journal Article
      MRAP2 inhibits β-arrestin recruitment to the ghrelin receptor by preventing GHSR1a phosphorylation
      Rouault AAJ, Buscaglia P, Sebag JA. Journal of Biological Chemistry, 2022 Jun 1; 298 (6): DOI:10.1016/j.jbc.2022.102057
      PMID: 35605660
    • Journal Article
      A putative long noncoding RNA-encoded micropeptide maintains cellular homeostasis in pancreatic β cells
      Li M, Shao F, Qian Q, Yu W, Zhang Z, Chen B, Su D, Guo Y, Phan AV, Song LS, Stephens SB, Sebag J, Imai Y, Yang L, Cao H. Molecular Therapy Nucleic Acids, 2021 Dec 3; 26: 307 - 320. DOI:10.1016/j.omtn.2021.06.027
    • Journal Article
      Role of N-Linked Glycosylation in PKR2 Trafficking and Signaling
      Verdinez JA, Sebag JA. Frontiers in Neuroscience, 2021 Aug 13; 15: DOI:10.3389/fnins.2021.730417
    • Journal Article
      Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer
      Bui TM, Butin-Israeli V, Wiesolek HL, Zhou M, Rehring JF, Wiesmüller L, Wu JD, Yang GY, Hanauer SB, Sebag JA, Sumagin R. Gastroenterology, 2021 Jul 1; 161 (1): 225 - 238.e15. DOI:10.1053/j.gastro.2021.03.027
      PMID: 33753103